Uttarakhand News Today

Connected Drug Delivery Devices Market to Hit USD 10552.30 Mn. by 2029 Qualitative and Quantitative Analysis By 2029

 Breaking News
  • No posts were found

Connected Drug Delivery Devices Market to Hit USD 10552.30 Mn. by 2029 Qualitative and Quantitative Analysis By 2029

December 08
13:40 2022
Connected Drug Delivery Devices Market to Hit USD 10552.30 Mn. by 2029 Qualitative and Quantitative Analysis By 2029
Connected Drug Delivery Devices Market
Connected Drug Delivery Devices Market size was valued at USD 896.35 Mn. in 2021 and the total Connected Drug Delivery Devices revenue is expected to grow at a CAGR of 36.10% from 2022 to 2029, reaching nearly USD 10552.30 Mn.

Pune,7, Dec2022: The Connected Drug Delivery Devices Market report published by Maximize market Research, the market is expected to grow from USD 896.35 million in 2021 to USD 10552.30 million in 2029, at a CAGR of 36.10 percent for the forecast period from 2022 to 2029.

Connected Drug Delivery Devices Market Scope and Research Methodology

The connected drug delivery devices market research report offers a thorough examination of the Connected Drug Delivery Devices market. The connected drug delivery devices market is estimated in terms of USD value from 2022 to 2029 in the study. The study provides an analytical picture of the Connected Drug Delivery Devices Market together with current trends and future forecast in order to identify prospective investment opportunities. The market share for Connected Drug Delivery Devices is thoroughly examined in the study, along with information on significant drivers, constraints, and opportunities. In order to demonstrate the potential for market expansion globally a quantitative study of the current market is conducted from 2021 to 2029.

For the competitive analysis of the Connected Drug Delivery Devices Market, major manufacturers in the industry are listed by region, revenue, financial status, portfolio, technological advancements adopted, mergers and acquisitions, joint venture and strategic alliances in detail. New entrants in the market are also listed with an analysis of their growth prospects and future business outlook. Such analysis acts as a guide for stakeholders, investors, market players and followers and new entrants with an overall view of the Connected Drug Delivery Devices Market for formulating investment approaches and marketing tactics.

Segment-wise analysis of the Connected Drug Delivery Devices Market was done by product, technology, disease indication type, treatment type, and end-user to understand the factors affecting the market growth positively and negatively. This provided a clear picture of the goods and services being offered in the Connected Drug Delivery Devices Market that aids the decision-making process for companies. The bottom-up approach was employed to validate the market size and its estimation by different segments. Report was extensively based on both primary and secondary data for the market analysis. The study of various industry-affecting factors, such as government policy, the market environment, the competitive landscape, historical data, current market trends, technological development, upcoming technologies, and the technical advancement in related industries, as well as market risks, opportunities, barriers, and challenges, was a part of the research process. PESTLE was employed to understand the potential impact of the micro-economic factors affecting the Connected Drug Delivery Devices Market.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.maximizemarketresearch.com/request-sample/20678 

Connected Drug Delivery Devices Market Overview

Adherence monitors, dose reminders, patient records to gather health information, and possibilities for patient education are just a few of the features offered by linked drug delivery systems. These tools are commonly used in the management of cardiovascular illnesses, COPD, diabetes, and asthma. Various market participants are developing devices to help in improved patient monitoring and therapy.

Connected Drug Delivery Devices Market Dynamics

The connected drug delivery devices market is seeing strong growth due to the increased incidence of chronic diseases including diabetes, COPD, and asthma throughout the world. COPD and asthma are two of the most common lung diseases around the globe. COPD is the third leading cause of death globally. Connected Drug Delivery Devices are increasingly preferred over manual drug administration methods due to their superior advantages. One of the key elements expected to boost the adoption of connected medication delivery devices throughout the forecast period is a greater importance on preventative medicine.

The Connected Drug Delivery Devices industry will rise due to the rising use of cutting-edge technology in these products. By cutting-edge technologies, major industry participants are producing effective connected drug delivery systems. Thanks to technological improvements, a number of recent as well as established firms are investing in and concentrating more on linked medicine delivery devices.

The growth of the linked medicine delivery device industry is expected to be constrained by worries about patient data security. The privacy of patient data may be seriously impacted by the loss of vital information, such as insurance IDs and medical records that may contain bank information, medical information, and location, and as a result, the reputation of the manufacturer of connected drug delivery devices may suffer. The risk posed by cyber security attacks may affect hospitals, patients, and outside service providers. The connected drug delivery device solutions’ considerable and severe risks might reduce market revenue over the course of the forecast period.

Connected Drug Delivery Devices Market Regional Insights

The North American regional market dominated the global connected drug delivery devices market with share of around 38% in 2021. Thanks to high per capita healthcare spending, quick adoption of new technology and equipment, and increased awareness of the negative effects of noncompliance with drug therapy, the area is expected to continue its leadership by the conclusion of the projection period. With wearable injectors and pen injectors, increasing awareness of the availability of several innovative drug delivery systems has significantly assisted the development of such devices in North America. 

The connected drug delivery devices market in Asia-Pacific is expected to expand at a CAGR of 24.25%. Thanks to its high per capita healthcare spending, growing public awareness of new, technologically sophisticated devices, and growing government activities related linked medication delivery devices, the area is expected to maintain its position over the projection period. 

Connected Drug Delivery Devices Market Segmentation 

By Product: 

  • Connected Sensors
  • Integrated Connected Device

By Technology:

  • Bluetooth
  • NFC
  • Other Technologies

By Disease Indication Type: 

  • Gastric Neuroendocrine Tumours
  • Lung Neuroendocrine Tumours
  • Pancreatic Neuroendocrine Tumours
  • Appendiceal Neuroendocrine Tumours

By Treatment Type: 

  • Somatostatin Analogs
  • Targeted Therapy
  • Chemotherapy

By End-User:

  • Healthcare Providers
  • Homecare Centres

Connected Drug Delivery Devices Market Key Manufacturers are: 

  • Propeller Health (U.S.)
  • West Pharmaceutical Services, Inc. (U.S.)
  • 3M Company (U.S.)
  • OPKO Health (U.S.)
  • Cohero Health (U.S.)
  • BD (U.S.)
  • Antares Pharma (New Jersey)
  • Johnson & Johnson Services, Inc. (U.S.)
  • ViVO Smart Medical Devices Ltd. (U.K.)
  • Bayer AG (Germany)
  • Sagentia (U.K.)
  • Biocorp Production SA (France)
  • CeQur SA (Switzerland)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis AG (Switzerland)
  • Sulzer Ltd. (Switzerland)
  • Gerresheimer AG (Germany)
  • Sanofi (France)
  • Bayer AG (Germany)
  • GlaxoSmithKline plc. (U.K.)
  • Novosanis (Belgium)
  • MEDMIX SYSTEMS AG. (Switzerland)
  • Care TRx (India)
  • SMC Ltd. (India)

Key questions answered in the Connected Drug Delivery Devices Market are: 

  • What is the Connected Drug Delivery Devices growth? 
  • Who are the key players in Connected Drug Delivery Devices market? 
  • Which region will lead the Connected Drug Delivery Devices market? 
  • Who are the major players operating in the Connected Drug Delivery Devices market?
  • Who are the market leaders in Connected Drug Delivery Devices in Europe?
  • Who are the market leaders in Connected Drug Delivery Devices in USA and Canada?
  • Who are the market leaders in Connected Drug Delivery Devices in India, China, Japan and South Korea?
  • What are the factors affecting growth in the Connected Drug Delivery Devices Market? 
  • Who held the largest market share in Connected Drug Delivery Devices Market? 
  • What are the factors for the growth of Asia-Pacific region in Connected Drug Delivery Devices Market?

For Detailed insights on this market, request for methodology here @ https://www.maximizemarketresearch.com/request-sample/20678 

Key Offerings:

  • Market Share, Size & Forecast by Revenue | 2022−2029
  • Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
  • Market Segmentation – A detailed analysis by product, technology, disease indication type, treatment type, and end-user and Region.
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Maximize Market Research is leading healthcare industry research firm, has also published the following reports:

Wearable Injectors Market –The Wearable Injectors Market size is expected to reach USD 25.07 billion by 2029 at a CAGR of 15.2 percent during the forecast period. Numerous chronic diseases including diabetes, heart problems, neurological disorders, and oncological disorders, are becoming more common due to the growing world population. This has led to increased demand for effective treatment choices. Wearable Injectors Market is expected to be driven by the increasing diseases across the world.

Drug Discovery Outsourcing Market –The Drug Discovery Outsourcing Market size is expected to reach USD 5.89 billion by 2029 at a CAGR of 7.4 percent during the forecast period. The advancement of the sector is being greatly aided by technological advancements in in silico drug creation and the quickening incorporation of AI in drug detection. There are several prospects for businesses to offer specialised drug discovery facilities thanks to the use of AI algorithms in drug development and design.

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Bangalore Highway, Narhe,

Pune, Maharashtra 411041, India

[email protected]

+91 96071 95908, +91 9607365656

Media Contact
Company Name: MAXIMIZE MARKET RESEARCH PVT. LTD.
Contact Person: Geeta Yevle
Email: Send Email
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,
City: Pune
State: Maharashtra
Country: India
Website: https://www.maximizemarketresearch.com/market-report/global-connected-drug-delivery-devices-market/20678/

Related Articles